相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。LDL-C and CRP lowering with atorvastatin in south Asians and Caucasians: Insights from the ACTFAST study
M. Gupta et al.
ATHEROSCLEROSIS SUPPLEMENTS (2007)
Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS trial)
Prakash C. Deedwania et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: The Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study
P. Martineau et al.
ATHEROSCLEROSIS (2007)
Safety and efficacy of statins in Asians
James K. Liao
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Canadian Cardiovascular Society position statement - Recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease
Ruth McPherson et al.
CANADIAN JOURNAL OF CARDIOLOGY (2006)
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
E Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
HM Colhoun et al.
LANCET (2004)
A review and assessment of potential sources of ethnic differences in drug responsiveness
TD Bjornsson et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvalstaltin, and pravastatin across doses (STELLAR* trial)
PH Jones et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Effects of low-dose pravastatin on plasma levels of lipids and apolipoproteins in Japanese type II hyperlipoproteinemic subjects with apolipoprotein E phenotype E3/2, E3/3, and E4/3
T Kobayashi et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2001)
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
SS Anand et al.
LANCET (2000)